Financhill
Sell
43

LQDA Quote, Financials, Valuation and Earnings

Last price:
$13.57
Seasonality move :
-8.34%
Day range:
$13.11 - $13.87
52-week range:
$8.26 - $16.81
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
74.73x
P/B ratio:
14.67x
Volume:
678.7K
Avg. volume:
1.1M
1-year change:
--
Market cap:
$1.1B
Revenue:
$14M
EPS (TTM):
-$1.67

Analysts' Opinion

  • Consensus Rating
    Liquidia has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $26.78, Liquidia has an estimated upside of 101.49% from its current price of $13.29.
  • Price Target Downside
    According to analysts, the lowest downside price target is $20.00 representing 100% downside risk from its current price of $13.29.

Fair Value

  • According to the consensus of 7 analysts, Liquidia has 101.49% upside to fair value with a price target of $26.78 per share.

LQDA vs. S&P 500

  • Over the past 5 trading days, Liquidia has overperformed the S&P 500 by 0.91% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Liquidia does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Liquidia revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Liquidia reported revenues of $2.9M.

Earnings Growth

  • Liquidia has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Liquidia reported earnings per share of -$0.46.
Enterprise value:
1.1B
EV / Invested capital:
--
Price / LTM sales:
74.73x
EV / EBIT:
--
EV / Revenue:
76.63x
PEG ratio (5yr expected):
-0.20x
EV / Free cash flow:
-10.53x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$8.1M
Return On Assets:
-66.8%
Net Income Margin (TTM):
-931.65%
Return On Equity:
-169.75%
Return On Invested Capital:
-119.52%
Operating Margin:
-1237.81%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $15.9M $17.5M $14M $4.5M $2.9M
Gross Profit $13.1M $14.6M $8.1M $3.5M $1.6M
Operating Income -$38.8M -$73.4M -$121.3M -$26.4M -$36.1M
EBITDA -$35M -$70.1M -$115.7M -$25M -$33.5M
Diluted EPS -$0.68 -$1.20 -$1.67 -$0.42 -$0.46
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $66.1M $61.3M $99.8M $89.9M $185.1M
Total Assets $99.5M $93.7M $129.2M $118.3M $230.3M
Current Liabilities $11.7M $7.3M $8.8M $18.6M $41.8M
Total Liabilities $28.4M $28.5M $38.8M $71M $153M
Total Equity $71.1M $65.3M $90.4M $47.3M $77.3M
Total Debt $10.3M $10.4M $19.9M $46M $115.4M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations -$28.6M -$41.6M -$93.4M -$16M -$20.8M
Cash From Investing -$587K -$11.3M -$8.4M -$206K -$4.8M
Cash From Financing $65M $43.2M $194.7M $23.6M -$2.3M
Free Cash Flow -$29.2M -$52.9M -$101.9M -$16.2M -$25.6M
LQDA
Sector
Market Cap
$1.1B
$34.2M
Price % of 52-Week High
79.06%
42.23%
Dividend Yield
0%
0%
Shareholder Yield
-16.23%
-0.82%
1-Year Price Total Return
--
-41.76%
Beta (5-Year)
0.226
0.737
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $13.34
200-day SMA
Buy
Level $12.16
Bollinger Bands (100)
Sell
Level 11.59 - 15.29
Chaikin Money Flow
Buy
Level 26.2M
20-day SMA
Sell
Level $13.92
Relative Strength Index (RSI14)
Sell
Level 43.63
ADX Line
Sell
Level 30.91
Williams %R
Neutral
Level -46.9974
50-day SMA
Sell
Level $14.83
MACD (12, 26)
Sell
Level -0.38
25-day Aroon Oscillator
Sell
Level -48
On Balance Volume
Neutral
Level 58.5M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-0.3785)
Sell
CA Score (Annual)
Level (-4.1387)
Buy
Beneish M-Score (Annual)
Level (-3.6111)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (4.4782)
Sell
Piotroski F Score (Annual)
Level (2)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Stock Forecast FAQ

In the current month, LQDA has received 6 Buy ratings 1 Hold ratings, and 0 Sell ratings. The LQDA average analyst price target in the past 3 months is $26.78.

  • Where Will Liquidia Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Liquidia share price will rise to $26.78 per share over the next 12 months.

  • What Do Analysts Say About Liquidia?

    Analysts are divided on their view about Liquidia share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Liquidia is a Sell and believe this share price will drop from its current level to $20.00.

  • What Is Liquidia's Price Target?

    The price target for Liquidia over the next 1-year time period is forecast to be $26.78 according to 7 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is LQDA A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Liquidia is a Buy. 6 of 7 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of LQDA?

    You can purchase shares of Liquidia via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Liquidia shares.

  • What Is The Liquidia Share Price Today?

    Liquidia was last trading at $13.57 per share. This represents the most recent stock quote for Liquidia. Yesterday, Liquidia closed at $13.29 per share.

  • How To Buy Liquidia Stock Online?

    In order to purchase Liquidia stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is TSMC the Best Semiconductor Stock to Buy Now?
Is TSMC the Best Semiconductor Stock to Buy Now?

The new administration has launched a slew of tariffs, paused…

Rocket Lab Vs Intuitive Machines Stock
Rocket Lab Vs Intuitive Machines Stock

The commercialization of outer space is now in full swing,…

Is The Trade Desk a Screaming Buy?
Is The Trade Desk a Screaming Buy?

One factor that sets programmatic advertising platform The Trade Desk…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 30x

Sell
40
Is NVDA Stock a Buy?

Market Cap: $2.4T
P/E Ratio: 33x

Alerts

Sell
9
UNH alert for Apr 22

UnitedHealth Group [UNH] is down 0.32% over the past day.

Buy
70
IIIN alert for Apr 22

Insteel Industries [IIIN] is up 3.06% over the past day.

Buy
58
AGX alert for Apr 22

Argan [AGX] is up 3.31% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock